MedPath
NMPA Approval

Peramivir Injection

国药准字H20244617

August 5, 2024

Drug Information

帕拉米韦注射液

注射剂

20ml∶0.2g(按C₁₅H₂₈N₄O₄计)

化学药品

August 5, 2024

Company Information

Applicant Company

安徽省芜湖市高新技术产业开发区长江南路152号

Manufacturing Company

安徽省芜湖市高新技术产业开发区长江南路152号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath